Researchers at the University of Leuven in Belgium have discovered a new potential treatment approach for melanoma. As this form of cancer is often resistant to standard chemotherapy treatment, Drs. Gembarska and Marine, lead researchers for this study, confirm that combination therapies, "combating the interaction between the protein MDM4 and the tumor suppressor p53" hold promise for melanoma patients.
To read more about the study, click here.
Study mentioned: Gembarska A et al. MDM4 is a ley therapeutic target in cutaneous melanoma. Nat Med. 2012 Jul. 22 [Epub ahead of print]. PMID 22820643
No comments:
Post a Comment